Kumar Rakhi

CIK 00018562962 companiesMOUNTAIN VIEW, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001856296

Recent Transactions

50 trades

Award
NeuroPace Inc$NPCE
Common Stock
2026-03-20$13.00/sh+1,153→ 19,160 total
Award
NeuroPace Inc$NPCE
Common Stock
2025-09-19$9.94/sh+1,509→ 17,103 total
Award
NeuroPace Inc$NPCE
Common Stock
2025-06-21$10.41/sh+1,440→ 15,594 total
Award
NeuroPace Inc$NPCE
Stock Option (right to buy)
2025-06-06+8,745→ 8,745 total
Award
NeuroPace Inc$NPCE
Common Stock
2025-03-21$12.02/sh+1,247→ 14,154 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2025-02-20$10.72/sh−958→ 162,306 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2025-02-13$3.85/sh+187,500→ 390,764 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-02-13−187,500→ 312,500 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-02-13$10.43/sh−227,500→ 163,264 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2025-01-20$11.15/sh−1,057→ 203,264 total
Award
NeuroPace Inc$NPCE
Common Stock
2024-12-21$11.53/sh+1,300→ 12,907 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-12-20$11.57/sh−3,087→ 204,321 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-11-20$11.49/sh−958→ 207,408 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-10-20$11.92/sh−956→ 208,366 total
Award
NeuroPace Inc$NPCE
Common Stock
2024-09-30$6.97/sh+2,152→ 11,607 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2024-09-23−250,000→ 500,000 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2024-09-23$11.89/sh−250,000→ 209,322 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2024-09-23$3.85/sh+250,000→ 459,322 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-09-20$11.97/sh−3,087→ 209,322 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-08-20$11.48/sh−958→ 212,409 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-07-20$11.00/sh−958→ 213,367 total
Award
NeuroPace Inc$NPCE
Common Stock
2024-06-28$7.56/sh+1,984→ 9,455 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-06-20$10.80/sh−3,087→ 212,123 total
Award
NeuroPace Inc$NPCE
Stock Option (Rt to Buy)
2024-06-07+17,774→ 17,774 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-05-20$11.37/sh−1,363→ 215,210 total
Award
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2024-04-22+230,548→ 230,548 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2024-04-22−38,685→ 216,573 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-04-20$10.46/sh−9,881→ 177,888 total
Award
NeuroPace Inc$NPCE
Common Stock
2024-03-29$13.20/sh+1,136→ 7,471 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-03-20$10.01/sh−1,506→ 187,769 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-02-20$11.54/sh−1,508→ 189,275 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2024-01-20$10.35/sh−1,506→ 190,783 total
Award
NeuroPace Inc$NPCE
Common Stock
2023-12-29$10.31/sh+1,454→ 6,335 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-12-27$11.50/sh−1,894→ 87,126 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-12-27+13→ 192,295 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2023-12-27$11.58/sh−6→ 192,289 total
Tax Payment
Roivant Sciences Ltd.$ROIV
Common Shares
2023-12-20$9.96/sh−1,364→ 192,282 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2023-11-22$8.68/sh−1,415→ 193,646 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2023-10-24$8.99/sh−1,563→ 195,061 total
Award
NeuroPace Inc$NPCE
Common Stock
2023-09-29$9.73/sh+1,541→ 4,881 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-28$12.67/sh−92→ 196,624 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-27+169→ 196,716 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Capped Value Appreciation Rights
2023-09-27$11.50/sh−1,894→ 80,020 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-22$10.19/sh−1,403→ 196,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-08$6.48/sh+99,350→ 297,300 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-08$12.18/sh−99,350→ 197,950 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2023-09-08−99,350→ 0 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2023-09-05−1,724→ 99,350 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-05$6.48/sh+1,724→ 199,674 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-05$12.00/sh−1,724→ 197,950 total

Companies

Recent Filings

Address

C/O NEUROPACE, INC. 455 N. BERNARDO AVENUE

MOUNTAIN VIEW, CA, 94043

View on SEC.gov